Filing Details
- Accession Number:
- 0001209191-17-031852
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-12 15:24:10
- Reporting Period:
- 2017-05-12
- Filing Date:
- 2017-05-12
- Accepted Time:
- 2017-05-12 15:24:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000694 | Novavax Inc | NVAX | Biological Products, (No Disgnostic Substances) (2836) | 222816046 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1051997 | Jr A Michael Mcmanus | C/O Novavax, Inc. 20 Firstfield Road Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-12 | 20,000 | $0.97 | 277,590 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9696 to $0.97, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Billionaire Hedge Funds
